Introduction … Trumprx!

by

Would you like to look at the cost of drugs of 40-85%cut pamphlet?

It is coming and it is coming through something new called “Trumprx”.

you will love it:

Post There was more information here:

President Trump on Tuesday announced to launch a new website, which gave Americans a chance to buy drugs directly from the government instead of going through insurance.

79 -year -old Trump also announced that Fizer plans to reduce its prices on some drugs distributed in the US, predicting Americans “hundreds of millions of dollars per year”.

Trump told reporters on the South Lawn of the White House before the announcement, “I think it is one of the biggest things.

The President said at the Oval Office, “Fizer Medicade is committed to offering all its prescription drugs, and it will be at the most preferred nation prices.” “It is going to make a big impact on bringing the medicade cost down as if nothing else.”

Most favorite nations (MFN) prices are calculated by taking pure consumer prices and comparing them against their rich countries.

Then the price is interacted keeping the US market in mind.

Trump said that Fizer also agreed to provide some of its popular drugs at a concessional rates between 50 and 100%, and all the new drugs declared would be introduced to the US at the most preferred nation rate, Trump said.

In drugs available on trumprx at low rate, rheumatoid is Xeljanz for arthritis (40%discount), zavzpret (50%) for migrants, eucrisa for dermatitis (80%), and duavee for female osteoporosis (85%).

See President Trump announces here:

I do not like relations with Albert Borla, but I suspect that it is probably a case of “keeping my enemies closer”:

Full fact sheet is direct from here Whitehouse.gov,

Fact Sheet: President Donald J. Trump announces the first deal to bring the pricing of the most preferred countries for American patients

Powering the price of most preferred countries: Today, President Donald J. Trump announced the first agreement with a major pharmaceutical company, Fizer, to bring American drug prices with the lowest paid paid by other developed countries (most preferred nation, or MFN, value).

  • The agreement will provide access to the prices of MFN drug on each state Medicade program in the country on PFIZER products, resulting in many millions of dollars and continued the historical efforts of President Trump to strengthen the program for the weakest people.
  • The agreement ensures that foreign nations can no longer use price control for freeride on American innovation, which brings to the fugger market by guaranteeing MFN prices on all new drugs.
  • The agreement requires the physician to increase foreign revenue on existing products, which reveals the President’s strong US First US trade policies for the benefit of American patients.
  • The agreement requires a physical to offer drugs at a deeper exemption from the list price on selling directly to American patients.

Providing low cost: Today’s actions will result in solid cost savings for American patients and healthcare systems. Together, more than 100 million patients are affected by the treatment of physical drugs, and many of them will benefit from the President’s successful conversation of low prices for Americans. Examples include:

  • A topical ointment, eucrisa, directly purchased patients for atopic dermatitis will be made available at 80% discount.
  • A widely used oral drug for xeljanz, rheumatic, psoriatic arthritis and ulcerative colitis, will be available at 40% discount to patients directly.
  • ZavzPret, commonly used for migraine, will be sold directly to patients at 50% discount.

Eliminating global freeloiding on American pharmaceutical innovation: President Trump is taking decisive action to unbalance a system that allows pharmaceutical manufacturers to offer low prices to other rich countries, charging at a high prices.

  • According to recent data, the prices of American prices for brand-name drugs that pay the prices are more than three times the price of other organizations for the payment of economic cooperation and development nations, even after accounting for the discount manufacturers in the US.
  • The United States has less than five percent of the world’s population, yet about 75% of global drug gains comes from American taxpayers.
  • Drug manufacturers benefit from liberal research subsidy and heavy healthcare expenses by the US government. Instead of passing that benefit through American consumers, drug manufacturers gave their products abroad exemption to gain access to foreign markets and subsidized those discounts through high prices charged in the US. American drug-producer is giving subsidy to profits and foreign health systems, both in development and once drugs are sold.

To bring American patients first to keep: President Trump is promising for American patients that the political establishment did not believe they were possible.

  • On May 12, 2025, President Trump signed an executive order, titled: “The most preferred drug drug pricing for American patients, directing the administration” to take several action to bring the prices of American drugs to the same nations.
  • On July 31, 2025, President Trump sent letters to leading drug manufacturers, who underlines the steps that take them to reduce the prices of prescription drugs in the United States to match the lowest price offered in other developed countries.
  • President Trump has been tireless in his attempt to address unfair and derogatory prices that Americans have paid for prescription drugs:
    • President Trump: “After the case, our citizens pay more prices on a large scale than other nations for the same precise pill, from the same factory, effectively giving subsidy to socialism [abroad] With skyrocketing prices at home. Therefore, we will spend tremendous amount of money to provide cheap medicines to another country. And when I say the price is different, you can see some examples where the price is beyond anything – four times, five times different. ,

ALSO READ  Look and see: Now passed with BBB, now cost costs ... You are loved what happens next! , WLT Report